Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Ravelcare IPO
Price Band
₹123.0–130.0
Issue Size
₹24.1 Cr
Lot Size
1,000 shares
Min Investment
₹260,000
2 LOTS MIN
GMP
+₹75.0 (57.69%)
Issue Price
₹130.0
Subject to Sauda
₹57000
Paid only if allotted
Ravelcare IPO AI Summary
- Ravelcare IPO is listed on BSE SME in the Personal Care sector.
- Price band: ₹123.0–₹130.0 per share, lot size 1,000 shares (min. investment ₹260,000, 2 lots minimum).
- Subscription window: 01 Dec–03 Dec 2025, listing on 08 Dec 2025.
- Current GMP is +₹75.0 (57.69%), an estimated listing price of ₹205 — unofficial and can change daily.
Ravelcare Ltd. is a modern beauty and personal care brand with a strong digital presence and a focus on customer-centric, innovative products. The company is set to utilize IPO proceeds for marketing, manufacturing, and general corporate purposes, aiming for growth in both domestic and international markets.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Ravelcare IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 03 Dec 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Ravelcare IPO Grey Market Premium (GMP) Today
GMP
+₹75.0
GMP %
+57.69%
Est. Listing
₹205.0
Updated: 25 Jul 2026 14:15
About the Company
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of haircare, skincare, bodycare, and scalp care products tailored to individual needs. The company operates primarily through its website and online marketplaces such as Amazon, Flipkart, and Myntra, along with quick commerce platforms like Blinkit. In FY 2024–25, Ravelcare expanded its presence internationally, catering to customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia. To ensure supply chain reliability and timely product delivery, the company manages logistics and warehousing operations across central Indian states. Additionally, Ravelcare plans to set up its integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility will house R&D, manufacturing, packaging, warehousing, and distribution under one roof. Product Offerings Ravelcare’s portfolio spans four key segments: Haircare: Includes shampoos, conditioners, masks, oils, and styling products tailored to concerns like hair fall, frizz, and damage from chemical treatments. Products are customized via digital consultations and are sold through online platforms. Skincare comprises cleansers, serums, moisturisers, sunscreens, and treatments for acne, dryness, pigmentation, and sensitivity. Customisation is based on digital skin assessments. Bodycare: Offers body washes and lotions designed for hydration, cleansing, and skin barrier repair, addressing conditions like dryness and sensitivity. Scalp Care: Features targeted treatments such as anti-dandruff tonics, hair growth serums, and approved hair fall control ampoules for issues like dryness, flaking, and buildup. As of June 30, 2025, the company employed 25 professionals across departments. Competitive Strengths Wide and Diversified Customer Base: The company serves a broad domestic and international customer base through a distributed warehousing model and third-party logistics, ensuring fast and reliable delivery. Digital-First Distribution: Operating primarily through D2C channels, Ravelcare reduces dependency on intermediaries and controls the entire customer journey—from discovery to delivery—allowing competitive pricing and consistent service. Customer-Centric Approach: Ravelcare builds strong relationships via a personalised digital consultation process, enabling the brand to understand individual needs and provide tailored product recommendations. Word-of-mouth from satisfied customers drives organic growth. Innovation-Led Product Development: The company continuously innovates based on customer feedback and digital interactions. Product development includes concept ideation, formulation, regulatory compliance, testing, and market positioning, driven by structured consumer insights. With its focus on personalisation, international expansion, and digital innovation, Ravelcare Ltd. positions itself as a modern, data-driven beauty and personal care brand addressing the evolving needs of customers globally.
Company Financials (₹ Cr)
As of 2025-09-30
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 15.68 | 11.63 | 8.03 | 1.74 |
| Total Income | 14.44 | 25.30 | 22.28 | 3.49 |
| Profit After Tax | 3.20 | 5.26 | 5.02 | 0.41 |
| EBITDA | 4.33 | 6.82 | 6.64 | 0.51 |
| NET Worth | 13.55 | 10.35 | 5.10 | 0.07 |
| Reserves and Surplus | 8.54 | 5.35 | 5.09 | 0.07 |
| Total Borrowing | 0.04 | 0.41 |
Key Ratios
EPS
₹10.50
NAV
₹20.67
ROE
68.04%
ROCE
68.32%
RoNW
50.77%
P/B Value
6.29
P/E Ratio
12.38
Market Cap
₹89.17 Cr
PAT Margin
21.01%
Promoters
Ayush Mahesh Verma
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand 11.50 2 Setting up a new manufacturing facility located at Mauje-Peth in Amravati (Proposed facility) 7.84 3 General Corporate Purposes 2.13 4 Issue Expenses 2.66 Total 24.14
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹3.49 Cr in the period ending 31 Mar 2023, rising to ₹22.28 Cr by 31 Mar 2024, and further increasing to ₹25.30 Cr by 31 Mar 2025. However, in the most recent period ending 30 Sep 2025, Total Income decreased to ₹14.44 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹0.41 Cr in the period ending 31 Mar 2023, increasing to ₹5.02 Cr by 31 Mar 2024, and further rising to ₹5.26 Cr by 31 Mar 2025. In the most recent period ending 30 Sep 2025, Profit After Tax was ₹3.20 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before the actual listing. A positive GMP suggests strong demand and potential for listing gains, while a negative GMP may indicate weaker demand.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, considering factors such as market conditions and individual financial goals.
Who May Want to Wait
Investors who are risk-averse or prefer stable, established companies may want to avoid IPOs like this, which can be subject to significant price fluctuations and uncertainties.
IPO Timeline, Explained
The IPO process includes several key dates: the issue opens on December 1, 2025, and closes on December 3, 2025. Allotment of shares is expected on December 4, 2025, with the listing date set for December 8, 2025.
Listing Gains — The Risk
Listing gains refer to the potential profit made when shares of an IPO are sold on the listing day. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and overall demand for the stock.
This evaluation is generated from Ravelcare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Ravelcare IPO GMP today?
Ravelcare IPO GMP today is +₹75.0 (57.69%), indicating an estimated listing price of ₹205. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Ravelcare IPO?
The price band of Ravelcare IPO is ₹123.0–₹130.0 per share.
When does Ravelcare IPO open and close?
Ravelcare IPO opens on 01 December 2025 and closes on 03 December 2025.
When does Ravelcare IPO list on the stock exchange?
Ravelcare IPO listed on 08 December 2025 at ₹205.0.
What is the lot size for Ravelcare IPO?
The lot size for Ravelcare IPO is 1000 shares, requiring a minimum investment of ₹260,000 (2 lots).
What is the price band for the Ravelcare IPO?
The price band for the Ravelcare IPO is ₹123.0 to ₹130.0.
What is the minimum investment required?
The minimum investment required is ₹260,000.
When does the Ravelcare IPO open and close?
The IPO opens on December 1, 2025, and closes on December 3, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO based on unofficial trading.
When is the listing date for Ravelcare?
The listing date for Ravelcare is December 8, 2025.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
01 Dec 2025
Close
03 Dec 2025
Allotment
04 Dec 2025
Listing
08 Dec 2025
Similar IPOs in Personal Care
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Ravelcare?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.